Swiss National Bank Sells 500 Shares of Addus HomeCare Corporation $ADUS

Swiss National Bank trimmed its position in shares of Addus HomeCare Corporation (NASDAQ:ADUSFree Report) by 1.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 35,100 shares of the company’s stock after selling 500 shares during the period. Swiss National Bank owned 0.19% of Addus HomeCare worth $3,471,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of the company. CenterBook Partners LP bought a new position in Addus HomeCare during the first quarter valued at $301,000. Empirical Financial Services LLC d.b.a. Empirical Wealth Management bought a new position in Addus HomeCare during the first quarter valued at $1,067,000. Vestcor Inc grew its holdings in Addus HomeCare by 156.1% during the first quarter. Vestcor Inc now owns 10,629 shares of the company’s stock valued at $1,051,000 after purchasing an additional 6,479 shares during the period. XTX Topco Ltd bought a new position in Addus HomeCare during the first quarter valued at $804,000. Finally, Premier Fund Managers Ltd bought a new position in Addus HomeCare during the first quarter valued at $726,000. 95.35% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. TD Cowen increased their price objective on Addus HomeCare from $135.00 to $139.00 and gave the company a “buy” rating in a report on Wednesday, August 6th. JMP Securities reissued a “market outperform” rating and set a $150.00 price objective on shares of Addus HomeCare in a report on Wednesday, July 16th. Macquarie reiterated an “outperform” rating and issued a $133.00 price target on shares of Addus HomeCare in a research report on Tuesday, June 10th. Wall Street Zen upgraded Addus HomeCare from a “hold” rating to a “buy” rating in a research report on Sunday, June 29th. Finally, Barclays lifted their price target on Addus HomeCare from $83.00 to $109.00 and gave the company an “underweight” rating in a research report on Tuesday. Two investment analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of $138.63.

Check Out Our Latest Stock Analysis on ADUS

Insider Transactions at Addus HomeCare

In related news, EVP Michael D. Wattenbarger sold 2,045 shares of Addus HomeCare stock in a transaction on Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total transaction of $235,175.00. Following the completion of the sale, the executive vice president owned 7,796 shares of the company’s stock, valued at approximately $896,540. This trade represents a 20.78% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 4.50% of the company’s stock.

Addus HomeCare Price Performance

Shares of NASDAQ ADUS opened at $114.85 on Thursday. The stock has a market cap of $2.11 billion, a PE ratio of 25.35, a price-to-earnings-growth ratio of 1.76 and a beta of 0.80. Addus HomeCare Corporation has a fifty-two week low of $88.96 and a fifty-two week high of $136.72. The stock has a fifty day moving average of $111.86 and a 200-day moving average of $107.21. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.74 and a current ratio of 1.74.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last posted its quarterly earnings data on Monday, August 4th. The company reported $1.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.45 by $0.04. The company had revenue of $349.44 million during the quarter, compared to analyst estimates of $345.71 million. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%.The firm’s quarterly revenue was up 21.8% on a year-over-year basis. During the same quarter last year, the company earned $1.35 earnings per share. Equities research analysts anticipate that Addus HomeCare Corporation will post 4.59 earnings per share for the current year.

Addus HomeCare Company Profile

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Featured Articles

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.